The role of nasal tolerance in a model of IgA nephropathy induced in mice by Sendai virus

Clinical Immunology

Volumn 113, Issue 1, 2004, Pages 101-108

  Amore, A ^a,b   Coppo, R ^a,b   Nedrud, J G ^c   Sigmund, N ^c   Lamm, M E ^c   Emancipator, S N ^c  

^a REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Glomerulonephritis; IgA; Mucosal tolerance; Nasal tolerance; Oral tolerance; Sendai virus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GLOMERULAR DYSFUNCTION; GLOMERULONEPHRITIS; GLOMERULUS; HEMATURIA; HOST; IMMUNIZATION; IMMUNOGLOBULIN A NEPHROPATHY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROVOCATION TEST; SENDAI VIRUS; VIREMIA; VIRUS INFECTIVITY; ANIMAL; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNE COMPLEX DISEASE; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; PROTEINURIA; RNA VIRUS INFECTION;

ANIMALS; FLUORESCENT ANTIBODY TECHNIQUE; HEMATURIA; IMMUNE COMPLEX DISEASES; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; KIDNEY; KIDNEY DISEASES; MICE; PROTEINURIA; RESPIROVIRUS INFECTIONS; SENDAI VIRUS;

EID: 6044237841     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2004.06.002     Document Type: Article

References (37)

1. Berger J., Hinglais N. Les depots intercapillaires d'IgA-IgG. J. Urol. 74:1968;694-695
2. Novak J., Julian B.A., Tomana M., Mestecky J. Progress in molecular and genetic studies of IgA nephropathy. J. Clin. Immunol. 21:2001;310-327
3. Floege J., Feehally J. IgA nephropathy: recent developments. J. Am. Soc. Nephrol. 11:2000;2395-2403
4. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am. J. Kidney Dis. 36:2000;227-237
5. Montenegro V., Monteiro R.C. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr. Opin. Rheumatol. 11:1999;265-272
6. Emancipator S.N. IgA nephropathy and Henoch-Schönlein syndrome. Jennette J.C., Olson J.L., Schwartz M.M., Silva F.G. Heptinstall's Pathology of the Kidney. fifth edition:1998;479-540 Lippincott-Raven, Philadelphia
7. Emancipator S.N., Mestecky J., Lamm M.E. IgA nephropathy. Mestecky J., Bienenstock J., Lamm M.E., Mayer L., McGhee J.R., Strober W. Mucosal Immunology. third ed.:2004;Elsevier, San Diego. in press
8. Coppo R., Basolo B., Piccoli G., Mazzucco G., Bulzomi M.R., Roccatello D., DeMarchi M., Carbonara A.O., Barbiano DiBelGiojoso G. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Schoenlein-Henoch nephritis. Clin. Exp. Immunol. 57:1984;583-589
9. Coppo R., Roccatello D., Amore A., Quattrocchio G., Molino A., Gianoglio B., Amoroso A., Bajardi P., Piccoli G. Effects of a gluten-free diet in primary IgA nephropathy. Clin. Nephrol. 33:1990;72-86
10. Gesualdo L., Lamm M.E., Emancipator S.N. Defective oral tolerance promotes nephritogenesis in experimental IgA nephropathy induced by oral immunization. J. Immunol. 145:1990;3684-3691
11. Emancipator S.N., Ovary Z., Lamm M.E. The role of mesangial complement in the hematuria of experimental IgA nephropathy. Lab. Invest. 57:1987;269-276
12. Chintalacharuvu S.R., Nagy N.U., Sigmund N., Nedrud J.G., Lamm M.E., Emancipator S.N. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin. Exp. Immunol. 126:2001;326-333
13. Emancipator S.N. Animal Models of IgA Nephropathy. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Coico R. Current Protocols in Immunology. 1999;15.11.1-15.11.18 Wiley, New York. Unit 15.11
14. Jessen R.H., Nedrud J.G., Jacobs G.H., Emancipator S.N. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status. Lab. Invest. 67:1992;379-396
15. Challacombe S.J., Tomasi T.B. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152:1980;1459-1472
16. Mattingly J.A., Kaplan J.M., Janeway C.A. Two distinct antigen-specific suppressor factors induced by the oral administration of antigen. J. Exp. Med. 152:1980;545-554
17. Saklayen M.G., Pesce A.J., Pollak V.E., Michael J.G. Kinetics of oral tolerance: study of variables affecting tolerance induced by oral administration of antigens. Int. Arch. Allergy Appl. Immunol. 73:1984;5-9
18. Gautam S.C., Battisto J.R. Orally induced tolerance generates an efferently acting suppressor cell and an acceptor T cell that together down-regulate contact sensitivity. J. Immunol. 135:1985;2975-2983
19. Holt P.G., McMenamin C. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy. 19:1989;255-262
20. Lowrey J.L., Savage N.D., Palliser D., Corsin-Jimenez M., Forsyth L.M., Hall G., Lindey S., Stewart G.A., Tan K.A., Hoyne G.F., Lamb J.R. Induction of tolerance via the respiratory mucosa. Int. Arch. Allergy Immunol. 116:1998;93-102
21. Bai X.F., Link H. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine. Clin. Exp. Allergy. 30:2000;1688-1696
22. Fujihashi K., Kato H., van Ginkel F.W., Koga T., Boyaka P.N., Jackson R.J., Kato R., Hagiwara Y., Etani Y., Goma I., Fujihashi K., Kiyono H., McGhee J.R. A revisit of mucosal IgA immunity and oral tolerance. Acta Odontol. Scand. 59:2001;301-308
23. Mestecky J., Husby S., Moldoveanu Z., Waldo F.B., van den Wall Bake A.W., Elson C.O. Induction of tolerance in humans: effectiveness of oral and nasal immunization routes. Ann. N. Y. Acad. Sci. 778:1996;194-201
24. Nedrud J.G., Liang X., Hague N., Lamm M.E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139:1987;3484-3492
25. Liang X., Lamm M.E., Nedrud J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 141:1988;1495-1501
26. Mazanec M.B., Lamm M.E., Lyn D., Portner A., Nedrud J.G. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 23:1992;1-12
27. Cole G.A., Hogg T.L., Woodland D.L. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1994;1767-1775
28. Cole G.A., Katz J.M., Hogg T.L., Ryan K.W., Portner A., Woodland D.L. Analysis of the primary T-cell response to Sendai virus infection in C57BL/6 mice: CD4+T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein. J. Virol. 68:1994;6863-6870
29. Chanock R.M., Parrott R.H., Johnson K.M., Kapikian A.Z., Bell J.A. Myxoviruses: parainfluenza. Am. Rev Respir. Dis. 88:1963;152-166
30. van Wyke Coelingh K.L., Winter C.C., Tierney E.L., Hall S.L., London W.T., Kim H.W., Chanock R.M., Murphy B.R. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin- neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus. J. Virol. 64:1990;3833-3843
31. Holt P.G., Vines J., Bilyk N. Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice. Int. Arch. Allergy Appl. Immunol. 86:1988;121-123
32. Bilyk N., Holt P.G. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology. 86:1995;231-237
33. Bilyk N., Holt P.G. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 177:1993;1773-1777
34. Kobayashi N., Bagheri N., Nedrud J.G., Strieter R.M., Tomino Y., Lamm M.E., Emancipator S.N. Differential effects of Sendai virus infection on mediator synthesis by mesangial cells from two mouse strains. Kidney Int. 64:2003;1675-1684
35. Isaacs K., Miller F., Lane B. Experimental model for IgA nephropathy. Clin. Immunol. Immunopathol. 20:1981;419-426
36. Imai H., Nakamoto Y., Asakura K., Miki K., Yasuda T., Miura A.B. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int. 27:1985;756-761
37. Launay P., Grossetete B., Arcos-Fajardo M., Gaudin E., Torres S.P., Beaudoin L., Patey-Mariaud de Serre N., Lehuen A., Monteiro R.C. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease): evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191:2000;1999-2009. Erratum in J. Exp. Med. 192:2000;309